Mariner, LLC Abcam PLC Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$21.54 - $24.41 $109,078 - $123,612	-5,064 Reduced 33.16%	10,206 $230,000
Q2 2023 Aug 11, 2023	BUY	$12.62 - $24.47 $40,888 - $79,282	3,240 Added 26.93%	15,270 $373,000
Q1 2023 May 12, 2023	SELL	$12.98 - $17.1 $66,834 - $88,047	-5,149 Reduced 29.97%	12,030 $162,000
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $95,449 - $116,569	6,857 Added 66.43%	17,179 $267,000
Q3 2022 Nov 10, 2022	BUY	$13.36 - $16.75 $137,901 - $172,893	10,322 New	10,322 $155,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.